CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY IN CHILDREN: DIAGNOSIS AND TREATMENT
https://doi.org/10.15690/vsp.v13i5.1150
Abstract
Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is a rare autoimmune disease of the peripheral nervous system. The article analyzes current international diagnostic criteria and clinical presentation features of the disease in childhood. The article discusses general principles of CIDP treatment and focuses on the pathogenetic therapies: intravenous immunotherapy using a standard human immunoglobulin (IVIG) with the content of IgG > 95%, prescription of large doses of glucocorticoids and plasmapheresis. It analyzes the recommendations for prioritizing the use of different types of treatment when initiating the therapy and describes the main drug prescription protocols and recommended doses. Two clinical cases of CIDP in children are described. It is shown that the use of adequate doses of IVIG, glucocorticoids and long-term maintenance treatment can completely reverse the symptoms of peripheral lesion, prevent repeated exacerbations of the disease and significantly improve the quality of life.
About the Authors
А.L. Kurenkov
Научный центр здоровья детей, Москва
Russian Federation
Russian Federation
L. M. Kuzenkova
Scientific Centre of Children Health, Moscow
Russian Federation
Scientific Centre of Children Health, Moscow
Russian Federation
Scientific Centre of Children Health, Moscow
S. S. Nikitin
2Association of Neuro-Muscular Disorders Specialists, Regional Non-Profit Organization, Moscow,
Russian Federation
Russian Federation
B. I. Bursagova
Scientific Centre of Children Health, Moscow
Russian Federation
Russian Federation
References
1. McLeod J. G., Pollard J. D., Macaskill P., Mohamed A., Spring P., Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann. Neurol. 1999; 46 (6): 910–913.
2. Connolly A. M. Chronic inflammatory demyelinating polyneuropathy. Сhildhood Pediatr. Neurol. 2001; 24: 177–182.
3. Nevo Y. Childhood chronic inflammatory demyelinating polyneuro pathy. Eur. J. Paediatr. Neurol. 1998; 2 (4): 169–177.
4. Markowitz J. A., Jeste S. S., Kang P. B. Child neurology: chronic inflammatory demyelinating polyradiculoneuropathy in children. Neurology. 2008; 71 (23): 74–78.
5. Hahn A. F., Hartung H-P., Dyck P. J. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Peripheral neuropathy. 4th ed. P. J. Dyck, P. K. Tomas (eds). Philadelphia: Elsevier/Saunders. 2005. P. 2221–2253.
6. Harvey G. K., Pollard J. D., Schindhelm K., Antony J. Chronic experimental allergic neuritis. An electrophysiological and histological study in the rabbit. J. Neurol. Sci. 1987; 81 (2–3): 215–225.
7. Korinthenberg R. Chronic inflammatory demyelinating polyradiculo neuropathy in children and their response to treatment. Neuropediatrics. 1999; 30 (4):190–196.
8. Jo H. Y., Park M. G., Kim D. S., Nam S. O., Park K. H. Chronic inflammatory demyelinating polyradiculoneuropathy in children: characterized by subacute, predominantly motor dominant polyeuropathy with a favorable response to the treatment. Acta. Neurol. Scand. 2010; 121 (5): 342–347.
9. Куренков А. Л., Бурсагова Б. И., Кузенкова Л. М., Никитин С. С. Особенности хронической воспалительной демиелинизирующей полинейропатии у детей. Нервно-мышечные болезни. 2012; 2: 40–51.
10. Luan X., Zhen R., Chen B., Yuan Y. Childhood chronic inflammatory demyelinating polyneuropathy with nonuniform pathologic features. Pediatr. Neurol. 2010; 43 (2): 103–109.
11. McMillan Y. J., Tarras B. T., Kang P. B. Autoimmune neuromuscular disorders in childhood. Current treatment options in Neurology. 2011; 13: 590–607.
12. Никитин С. С., Куренков А. Л. Особенности острой воспалительной и хронической демиелинизирующих полиневропатий у детей. В кн.: Аутоиммунные заболевания в неврологии. Клиническое руководство. Т. 2. Под ред. И. А. Завалишина, М. А. Пирадова, А. Н. Бойко, С. С. Никитина, Н. Н. Спирина. М.: Здо ровье человека. 2014. С. 63–75.
13. Simmons Z., Wald J. J., Albers J. W. Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve. 1997; 20 (8): 1008–1015.
14. Simmons Z., Wald J. J., Albers J. W. Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults. Muscle Nerve. 1997; 20 (12): 1569–1575.
15. Rabie M., Nevo Y. Childhood acute and chronic immunemediated polyradiculoneuropathies. Eur. J. Paediatr. Neurol. 2009; 13 (3): 209–218.
16. Nobile-Orazio E., Gallia F., Judica E. Chronic inflammatory demyelinating polyradiculoneuropathy and related disorders. In: Neuromuscular disorders in clinical practice. B. Katirji, H. J. Kaminski, R. L. Ruff (eds.). New York: Springer. 2014. P. 605–632.
17. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society — First Revision. J. Peripher. Nerv. Syst. 2010; 15 (1): 1–9.
18. Rossi D. P., Doria Lamba L., Pistorio A., Pedemonte M., Veneselli E., Rossi A. Chronic inflammatory demyelinating polyneuro pathy of childhood: clinical and neuroradiological findings. Neuro radiolo gy. 2013; 55 (10): 1233–1239.
19. McMillan H. J., Kang P. B., Jones H. R., Darras B. T. Childhood chronic inflammatory demyelinating polyradiculoneuropathy: combined analysis of a large cohort and eleven published series. Neuromuscul. Disord. 2013; 23 (2): 103–111.
20. Bansal V. K., Meriggioli M. N. Immunotherapy in the treatment autoimmune neuromuscular disease. In: Neuromuscular disorders in clinical practice. B. Katirji, H. J. Kaminski, R. L. Ruff (eds.). New York: Springer. 2014. P. 341–362.
21. Hughes R. A., Mehndiratta M. M. Corticosteroids for chronic inflam matory demyelinating polyradiculoneuropathy. Cochr. Database Syst. Rev. 2012; 8: CD002062.
22. Mehndiratta M. M., Hughes R. A. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochr. Database Syst. Rev. 2012; 9: CD003906.
23. Eftimov F., Winer J. B., Vermeulen M., de Haan R., van Schaik I. N. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochr. Database Syst. Rev. 2013; 12: CD001797.
24. Cocito D., Paolasso I., Antonini G., Benedetti L., Briani C., Comi C., Fazio R., Jann S., Mata S., Mazzeo A., Sabatelli M., NobileOrazio E. A nationwide retrospective analysis of the effect immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Eur. J. Neurol. 2010; 17: 289–294.
25. Rossignol E., D’Anjou G., Lapointe N., Haddad E., Vanasse M. Evolution and treatment of childhood chronic inflammatory polyneuropathy. Pediatr. Neurol. 2007; 36 (2): 88–94.
26. Sladky J. T. What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin? Muscle Nerve. 2008; 38 (6): 1638–1643.
27. Ware T. L., Kornberg A. J., Rodriguez-Casero M. V., Ryan M. M. Childhood chronic inflammatory demyelinating polyneuropathy: an overview of 10 cases in the modern era. J. Child Neurol. 2014; 29 (1): 43–48.
28. Dyck P. J., O'Brien P. C., Oviatt K. F., Dinapoli R. P., Daube J. R., Bartleson J. D., Mokri B., Swift T., Low P. A., Windebank A. J. Predni sone improves chronic inflammatory demyelinating polyradicu loneuropathy more than no treatment. Ann. Neurol. 1982; 11 (2): 136–141.
29. Ryan M. M., Grattan-Smith P. K., Procopis P. G., Morgan G., Ouvrier R. A. Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome. Neuromusc. Dis. 2000; 10: 298–406.
30. Hughes R. A., Swan A. V., van Doorn P. A. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy. Cochr. Database Syst. Rev. 2004; 4: CD003280.
31. Mahdi-Rogers M., Swan A. V., van Doorn P. A., Hughes R. A. Immunomodulatory treatment other than corticosteroids, immu noglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochr. Database Syst. Rev. 2010; 11: CD003280.
32. Dyck P. J., O'Brien P., Swanson C., Low P., Daube J. Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy. Neurology. 1985; 35 (8): 1173–1176.
33. Benedetti L., Briani C., Franciotta D., Fazio R., Paolasso I., Comi C., Luigetti M., Sabatelli M., Giannini F., Mancardi G. L., Schenone A., Nobile-Orazio E., Cocito D. Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature. J. Neurol. Neurosurg. Psychiatry. 2011; 82 (3): 306–308.
Review
For citations:
Kurenkov А., Kuzenkova L.M., Nikitin S.S., Bursagova B.I. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY IN CHILDREN: DIAGNOSIS AND TREATMENT. Current Pediatrics. 2014;13(5):47-54. (In Russ.) https://doi.org/10.15690/vsp.v13i5.1150
Views:
3034
Email this article 
